The comparative antidepressant value of lofepramine and amitriptyline

Abstract

A double-blind controlled trial comparing the antidepressant activity of amitriptyline with lofepramine is reported. Patients (46) entered the 4 wk trial. Analysis of the Hamilton Depression Rating Scale scores at the beginning and end of the trial showed no significant difference between the therapeutic efficacy of lofepramine and amitriptyline. Patients with endogenous depression responded significantly more rapidly to lofepramine as measured by Visual Analog Scales and showed a significantly greater degree of clinical improvement after 4 wk treatment, as measured by Global Assessment. Adverse effects were similar in the 2 treatment groups. The use of rating scales in trials of depressive illnesses is discussed. The Visual Analog Scale for depression was a simple, useful and valid measure.